FDA spending could be tightened under Republicans
This article was originally published in Scrip
Executive Summary
While there's a good chance the FDA could gain some new funding under the 21st Century Cures Initiative, which is being led by members of the House, once Republicans take control of the Senate in January, the agency's spending may come under tighter scrutiny, said Washington lawyer John R Manthei, a partner at Latham & Watkins and global co-chair of the firm's healthcare and life sciences practice.